Literature DB >> 2556809

AIDS and the lung. 2--Antiretroviral treatment in human immunodeficiency virus disease.

A J Pinching1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2556809      PMCID： PMC462157          DOI： 10.1136/thx.44.11.971

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  47 in total

1.  Clinical and virological effects of high-dose recombinant interferon-alpha in disseminated AIDS-related Kaposi's sarcoma.

Authors:  R de Wit; J K Schattenkerk; C A Boucher; P J Bakker; K H Veenhof; S A Danner
Journal:  Lancet       Date:  1988-11-26       Impact factor: 79.321

2.  Improvement of hepatic encephalopathy treated with flumazenil.

Authors:  G Grimm; P Ferenci; R Katzenschlager; C Madl; B Schneeweiss; A N Laggner; K Lenz; A Gangl
Journal:  Lancet       Date:  1988-12-17       Impact factor: 79.321

3.  Passive immunoneutralization of human immunodeficiency virus in patients with advanced AIDS.

Authors:  G G Jackson; J T Perkins; M Rubenis; D A Paul; M Knigge; J C Despotes; P Spencer
Journal:  Lancet       Date:  1988-09-17       Impact factor: 79.321

4.  Anti-retroviral effects of interferon-alpha in AIDS-associated Kaposi's sarcoma.

Authors:  H C Lane; J A Kovacs; J Feinberg; B Herpin; V Davey; R Walker; L Deyton; J A Metcalf; M Baseler; N Salzman
Journal:  Lancet       Date:  1988-11-26       Impact factor: 79.321

5.  Zidovudine-associated myopathy.

Authors:  M Helbert; T Fletcher; B Peddle; J R Harris; A J Pinching
Journal:  Lancet       Date:  1988-09-17       Impact factor: 79.321

6.  Myelopathy after stopping zidovudine.

Authors:  R H Loke; J P Wade; I M Murray-Lyon
Journal:  Lancet       Date:  1988-07-30       Impact factor: 79.321

7.  Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome.

Authors:  A Karpas; F Hill; M Youle; V Cullen; J Gray; N Byron; F Hayhoe; M Tenant-Flowers; L Howard; D Gilgen
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

8.  Results of continued monitoring of participants in the placebo-controlled trial of zidovudine for serious human immunodeficiency virus infection.

Authors:  D D Richman; J Andrews
Journal:  Am J Med       Date:  1988-08-29       Impact factor: 4.965

9.  Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex.

Authors:  F A Schmitt; J W Bigley; R McKinnis; P E Logue; R W Evans; J L Drucker
Journal:  N Engl J Med       Date:  1988-12-15       Impact factor: 91.245

10.  Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection.

Authors:  P A Pizzo; J Eddy; J Falloon; F M Balis; R F Murphy; H Moss; P Wolters; P Brouwers; P Jarosinski; M Rubin
Journal:  N Engl J Med       Date:  1988-10-06       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.